2427 — Guanze Medical Information Industry (Holding) Co Cashflow Statement
0.000.00%
- HK$722.00m
- HK$672.96m
- CNY156.07m
- 50
- 31
- 45
- 34
Annual cashflow statement for Guanze Medical Information Industry (Holding) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 29.6 | 39 | 33.1 | 30 | 38.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.069 | 1.21 | 2.6 | 1.2 | -3.98 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -26.2 | -15.3 | -37 | -27.1 | -31.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 5.51 | 28.2 | 3.09 | 9.31 | 8.85 |
Capital Expenditures | -9.83 | -14.4 | -7.86 | -9.33 | -7.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.051 | 0 | 0 | 0 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.83 | -14.3 | -7.86 | -9.33 | -7.3 |
Financing Cash Flow Items | -0.073 | 31.2 | 1.49 | -11.9 | -22 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.87 | -14.8 | 19.5 | 9.15 | 37.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.19 | -0.973 | 14.7 | 9.13 | 39 |